Moncton Company Starts New Human Trials For Cancer Drug Developed From Shrew Venom
Moncton-based Soricimed Biopharma is aiming to conduct a second phase of human trials for a cancer drug it is developing.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
Moncton Company Starts New Human Trials For Cancer Drug Developed From Shrew Venom
Moncton-based Soricimed Biopharma is aiming to conduct a second phase of human trials for a cancer drug it is developing.